What FDA Clearance Covers, and What General Wellness Means

Oct 8

6 min read

On October 5 FDA cleared a prescription digital therapeutic for one named condition, in adults at one described clinical state, to be used alongside care a clinician would be managing, with a list of patients it is not intended for. All of that sits in a single paragraph called the indication, and that paragraph is what a clearance is.

A man in glasses reads a printed document closely at a desk beside an office window.

Neurova Academy has no indication, because it has no clearance. It is a general wellness and cognitive training program, it is not a medical device, and it is not offered for any use that would require clearance or approval. Those are two categories with two sets of rules, and the terms for them get used loosely enough that a buyer cannot tell them apart from a brochure.

What an FDA clearance covers

A cleared product is cleared for what its indication says and for nothing past it. The October 5 indication is a single sentence. It permits one use, names the population, and attaches conditions to how the product is used. That is the document a buyer should ask for, and a summary of it is not the same thing.

The exclusions carry as much information as the permission. The product cleared on October 5 is not intended as a standalone therapy, not intended for acute symptoms, and not intended for several groups of patients named by their clinical history. A company holding a clearance has a document that tells it where to stop.

Three terms circulate in this category and they describe different things. Approval is a product-level decision, where FDA reviews a submission and approves a specific product for a specific use against a high standard. Clearance is also a product-level decision reached by a different route, where a company shows its product is substantially equivalent to one already legally on the market and FDA clears it for a stated use. Registration is an establishment listing, where a facility records with the agency that a company exists and makes something, with no product reviewed and no claim examined. "FDA registered" is the most flattering of those three terms and the least meaningful, and Neurova Labs does not use it.

What the general wellness category is, and what it does not imply

Neurova Academy sits in a different category, and the category has a governing document.

FDA describes it in General Wellness: Policy for Low Risk Devices, final guidance for industry and FDA staff, docket FDA-2014-N-1039, last modified January 6, 2026. The guidance sets out two kinds of general wellness intended use. The first covers claims about sustaining or offering general improvement to functions associated with a general state of health, with no reference to any disease or condition. The second covers claims that do reference a disease or condition, limited to relating a healthy lifestyle choice to reducing a risk or to living well with a chronic disease, where the role of that choice is well understood and accepted.

A product in the category also has to be low risk, which the guidance tests with three questions. Is the product invasive. Is it implanted. Does it involve an intervention or technology that may pose a risk to the safety of users and other persons if specific regulatory controls are not applied, such as risks from lasers or radiation exposure.

One sentence in the guidance is the one a buyer should hold onto, and it works against every company in the category including ours. FDA writes that "a product's inclusion under the general wellness policy in this guidance does not establish that it has been shown to be safe and/or effective for its intended use." The category describes what a company may say without its product becoming a regulated device. It records no opinion about the product's effectiveness. Anyone who tells you otherwise is selling.

The guidance also names the kinds of products it covers, and software programs are on that list by name.

Where Neurova Academy sits in the general wellness category

Neurova Academy is a general wellness and cognitive training program. It is not a medical device. It has no FDA approval and no FDA clearance, because it is not offered for any use that would require one. That wording is copied from our claims page, and the two sentences will stay identical.

The guidance does something we have never pointed at before, which is to enumerate examples of acceptable general wellness claims. Four of them are worth quoting, because they describe our vocabulary closely. FDA's examples include claims to promote relaxation or manage stress, claims to improve mental acuity, instruction following, concentration, problem-solving, multitasking, resource management, decision-making, logic, pattern recognition, or eye-hand coordination, claims to enhance learning capacity, and claims to promote sleep management such as to track sleep trends.

Neurova Academy is designed to support decision-making speed, sustained focus, and cognitive flexibility under pressure. That is the language on our technology page, and it was chosen before we read the current guidance. It sits inside FDA's own list of examples almost term for term, and that is where we intend to stay.

Staying there has a cost, and we pay it on purpose. Neurova Labs does not claim its program treats, cures, prevents, or diagnoses anything. We make no concussion, traumatic brain injury, or CTE claim, and we hold that line hardest in athletic and military settings, where the temptation is greatest and the people involved have the most to lose. We present cohort results as observational, with the participant count and the study beside every figure. We do not move a claim into a participant's mouth to avoid making it in our own. Those four commitments are set out in full on our claims page.

Measurement is the other half of the position. Neurova Labs offers an optional 22-marker panel reading RNA gene expression from whole blood, run through iXpressGenes, a CLIA-certified, CAP-accredited laboratory. It is designed to track inflammatory and immune signals associated with stress and recovery. It is not used to diagnose any condition, and our measurement page states its limits in full.

Intended use is read from everything a company publishes

The part of this that catches companies out is the copy.

FDA reads intended use from a product's labeling, its advertising, its promotion, and other statements a company makes about it. A page, a caption, a trade show handout, or a sentence a salesperson says in a booth can describe a use the company never meant to claim. The category boundary sits in the vocabulary a company uses.

A product leaves general wellness territory when it references a specific disease or condition, characterizes an output as abnormal or diagnostic, uses clinical thresholds, prompts or guides specific clinical action, provides ongoing disease management monitoring, or claims clinical accuracy or equivalence to a cleared device.

That has a practical consequence we accept rather than argue with. Our partner and reseller copy sits inside our own exposure, so we hold it to the same standard as our own pages. When a partner's site describes Neurova Academy in words we would not use, the fix is ours to ask for.

Five questions to ask any wellness vendor

Run these at any vendor in this category, starting with us.

Is the product cleared, approved, registered, or none of those? Ask for the term they would use in writing, and ask them to spell out what it covers.
If it is cleared or approved, what does the indication say? Ask for the indication itself rather than a summary of it.
If it is a general wellness product, which claims does the company make? Then check those claims against FDA's own examples in the January 6, 2026 guidance.
What has the company measured, and what was the study design? Ask for the participant count in the same sentence as any percentage.
Does the company hold its partners to the same claims? A vendor with no answer to this question has partners writing copy it has never read.

A company that answers all five without hedging has done the work. If anything on our site, in a deck, or in a conversation with our team contradicts this page, this page is the one we stand behind. Write to info@neurovalabs.com and we will fix the other one.

Neurova Academy is a general wellness and cognitive training program. It is not a medical device and is not offered to diagnose, treat, cure, or mitigate any disease or condition, including concussion, traumatic brain injury, or CTE. Outcomes described reflect observational pilot findings and individual experience, and are not a prediction of results for anyone else. Individual results vary. Laboratory testing provided by iXpressGenes, a CLIA-certified, CAP-accredited laboratory. References to FDA guidance documents and news reporting are for commentary only and do not imply endorsement of Neurova Labs by any federal entity. This page describes a regulatory category and is not legal advice.

Media contact: nathaniel.free@neurovalabs.com